Hyperandrogenism in pregnant women: ethiopathogenesis, diagnosis, treatment, perinatal outcomes (review)

1.  Abdurakhmanova R.A. Hyperandrogenism as a risk factor for obstetritional and perinatal pathology // III regional forum «Mother and child». Moscow, 2009. 5. (in Russian)
2. Agarkova L.A., Logvinov S.V., Dish O.G. et al. Morphological peculiarities of placenta in case of hyperandrogenism // Rossiyskiy vestnik akushera-ginekologa. 2006. 3. 16–19. (in Russian)
3. Babichev V.N. Neuroendocrinology of reproductive system // Problemy endokrinologii. 1998. (1). 3–12. (in Russian)
4. Barkhatova T.P., Lyashko E.S., Fanchenko N.V. Adrenal hyperandrogenism as cause factor for high risk pregnancy and perinatal pathology // Miscarriage of pregnancy. Moscow, 1984. 78–89. (in Russian)
5. Botkina T.V. Complex estimation of the reproductive system state in women with hyperandrogenism: abstract of thesis…candidate of medical sciences. Novosibirsk, 2001. (in Russian)
6. Vasil^,eva V.V. Spectral characteristics of the brain bioelectrical activity in pregnant women with hyperandrogenia in anamnesis // Valeologiya. 2010. (3). 14–18. (in Russian)
7. Vikhlyaeva E.M. Handbook on endocrinal gynaecology. Moscow, 2002. 360–395. (in Russian)
8. Volkova N.I., Dimitriaidi T.A. Diagnostics of hyperandrogenism in real practice (retrospective review) // Fharmateka. 2009. 17. 48–51. (in Russian)
9. Gabitova N.A., Agarkova L.A., Udut V.V. Metabolism of the porphyrins in pregnant with placental insufficiency and hyperandrogenia // Sibirskiy meditsinskiy zhurnal. 2010. 25. (4). 48–51. (in Russian)
10. Glazkova O.I. Optimization of the diagnostics and therapy for infertility in women with chronical anovulation and hyperandrogenasm: abstract of thesis… candidate of medical science. Moscow, 1999. (in Russian)
11. Grodnitskaya E.E., Kurtser M.A. Hyrsutism: pathogenesis, clinics, diagnosis, treatment // Akusherstvo i ginekologiya. 2012. 4. (1). 87–91. (in Russian)
12. Dedov I.I. Hyperandrogenism in women. Pathogenesis, clinical forms, differential diagnosis and treatment: Manual for doctors. Moscow, 2003. 42 р. (in Russian)
13. Durinyan E.R., Bayrabina G.V. Pathogenesis, differential diagnosis and principles of the treatment for hyperandrogenism // Akusherstvo i ginekologiya. 2002. (4). 62–64. (in Russian)
14. Dish O.G. Clinical morphological aspects of placental insufficiency in case of hyperandrogenia: abstract of thesis…candidate of medical sciences. Tomsk, 2010. (in Russian)
15. Yen S.S.K. Physiology of androgens in women // Reproduktivnaya endokrinologiya. 1998. (1). 617–684. (in Russian)
16. Kachalina T.S. Hyperandrogenism and miscarriage of pregnancy // Rossiyskiy vestnik akushera-ginekologa. 2004. (3). 61–64. (in Russian)
17. Kozlovene D., Kazanavichyus G., Kruminis V. Concentration of testosterone, dehydroepiandrosterone sulfatis and idexes of free androgens in women with hyperandrogenism // Problemy endokrinologii. 2008. 54. (2). 42–46. (in Russian)
18. Komarov E.K. Reproductive function in women with peripheral hyperandrogenism // Zhurnal akusherstva i zhenskikh bolezney. 2009. 58. (4). 57–62. (in Russian)
19. Krasnopolskaya K.V., Kalugina A.S. Diagnostics and therapy for hyperandrogenism in IVF program (rewiew) // Problemy reproduktsii. 2004. (5). 25–29. (in Russian)
20.  Lipsett M.B. Steroid hormones // Reproduktivnaya endokrinologiya. 1998. (1). 193–211. (in Russian)
21. Lyashko E.S., Sonich M.G., Timopheev S.A. Influence of the hyperandrogenism on the women reproductive function // Meditsinskaya pomoshch. 2000. (4). 22–25. (in Russian)
22. Magularia T.T. Characteristics of the ovarian and adrenal hormonal function in women with hyperandrogenism: abstract of the thesis…candidate of medical science. Moscow, 1993. (in Russian)
23. Manukhina E.I., Gevorkyan E.M., Kuznetsova E.M. Modern point of view on reproductive malfunction in case of hypeandrogenism // Problemy reproduktsii. 2011. 17. (2). 12–17. (in Russian)
24. Nelidova N.E., Gabitova N.A., Agarkova L.A. Psychological state of pregnant woman having hyperandrogenia in I trimester // Clinical biological problems of protection of mother and child mental health: abstracts. Tomsk, 2009. 99. (in Russian)
25. Pershina E.V. Reestablishment of the reproductive function in women having hyperandrogenia // Vrach. 2010. (7). 46–50. (in Russian)
26. Ragimova E.Z. Principles of the treatment for the clinical symptoms in women with hyperandrogenia // Rossiyskiy vestnik akushera-ginekologa. 2007. (6). 16–19. (in Russian)
27. Raisova A.T. Miscarriage of pregnancy in women with hyperandrogenia: abstract of thesis…doctor of medical science. Moscow, 1990. (in Russian)
28. Rogovskaya S.I. Angrogens and antiandrogens //Gynaecologist. 2004. (10). 13–21. (in Russian)
29. Rozen V.B. Receptors and steroid hormones. Moscow, 1981. 312 p. (in Russian)
30. Saidova R.A., Guseinova Z.S., Olimpieva S.P. Informativiness of hormonal pefomance for diagnostics of missed abortion incase of gyperandrogenia // Rossiyskiy vestnik akushera-ginekologa. 2011. 11. (4). 4–8. (in Russian)
31. Serov V.N., Prilepskaya V.N., Ovsyannikova T.V. Gynaecological endocrinology. Moscow, 2006. 488 p. (in Russian)
32. Sidelnikova V.M. Habitual loss of pregnancy. Moscow, 2002. 304 с. (in Russian)
33. Sidelnikova V.M. Glucocorticoids for obstetrics – the pros and cons // Akusherstvo i ginekologiya. 2010. (1). 3–5. (in Russian)
34. Suplotova L.A. The use of the glucocorticoids for androgen excess complication in pregnant women // Problemy reproduktsii. 2007. 13. (1). 92–95. (in Russian)
35. Chagay N.B. Complexity of differential diagnosis and therapy for non-classical adrenal hyperplasia in women of reproductive age // Problemy reproduktsii. 2009. 15. (3). 93–98. (in Russian)
36. Chernukha G.E. Hyperandrogenism and the princips of the therapy in reproductive age women // Meditsina. Kachestvo zhizni. 2004. (2). 17–20. (in Russian)
37. Shilin D.E. Syndrome of hyperandrogenism – modern diagnostics and new technologies // Lechashchiy vrach. 2003. (10). 36–39. (in Russian)
38. Shustikova E.F. Complications of glucocorticoid therapy in pregnancy // Problemy ginekologii, akushersyva i perinatologii. 2011. 10. (1). 40–42. (in Russian)

39. Amalfi S., Velez L.M., Heber M.F. et al. Prenatal hyperandrogenization induces metabolic and endocrine alterations which depends on the level of testosterone exposure // PloS One. 2012. 7. (5). e37658.

40. American Association of Clinical Endocrino­logists. Medical Guidelines for the clinical practice for the diagnosis and treatment of hyperandrogenic disorders // Endocr. Pract. 2001. 7. 121–134.

41. Androgen excess disorders in women: poly­cystic ovary syndrome and other disorders / Eds. R. Azziz, J.E.Nestler, D. Dewailly. 2-nd edition. Totowa: Humana Press, 2006. 466 p.

42. Barbieri R.L. Hyperandrogenic disorders // Clin. Obstet. Gynecol. 1990. 33. (3). 640–654.

43. Blanche H., Vexiau P., Clauin S. et al. Exhaustive screening of the 21-hydroxylase gene in a population of hyperandrogenic women // Hum. Genet. 1997. 101. (1). 56–60.

44. Bolton S., Cleary B., Walsh J. et al. Continuation of metformin in the first trimester of women with polycystic ovarian syndrome is not associated with increased perinatal morbidity // Eur. J. Pediatr. 2009. 168. 203–206.

45. Breckwoldt M. Diagnosis and therapy of andro­genization. Berlin: Diesbach Verglag, 1992. 253–267.

46. Burry J.A., Kay A.R., Navaratnarajak R. et al. Umbilical vein testosterone in female infants born to mathers with polycistic ovary syndrome is elevated to male levels // Obstet. Gynecol. 2010. 30. (3). 444–446.

47. Carmina E., Lobo R.A. Adrenal hyperandrogenism in the pathophysiology of polycystic ovary syndrome // J. Endocrinol. Invest. 1998. 21. (9). 580–588.

48. Chapman J.M., Wittert R.G., Norman R.J. Plasma androgen levels // Clin. Endocrinol. 1997. 46. (2). 175–181.

49. De Vana G.W., Czekala H.L., Judd H.L. Hype­randrogenia in syndrome polycystic ovarian // Am. J. Obstet. 1998. 35. 20–25.

50. Gonzales F. Adrenal involvement in polycystic ovary syndrome // Semin. Reprod. Endocrinol. 1997. 15. 137–157.

51. Ghazeeri G.S., Nassar A.H., Younes Z., Awward J.T. Pregnancy outcomes and the effect of metformin treatment in women with polycystic ovary syndrome: an overview // Acta Obstet. Gynecol. Scand. 2012. 96. (6). 658–678.

52. Ghorashi V., Sheikhvaten M. The relationship between serum concentration of free testosterone and pre-eclampsia // Endocrynol. Pol. 2008. 59. (5). 390–392.

53. Hickey M., Sloboda D.M., Atkison N.C. et al. The relationship between maternal and umbilical cord androgen levels and polycystic ovary syndrome in adolescence // J. Clin. Endocrinol. Metab. 2009. 94. (10). 3714–3720.

54. Kurtoglu S., Sarici D., Akin M.A. et al. Fetal adrenal suppression due to maternal corticosteroid use: case report // J. Clin. Res. Pediatr. Endocrinol. 2011. 3. (3). 160–162.

55. Lee J.Y., Park S.J., Kim S.H., Kim M.N. Prenatal administration of dexamethasone during early pregnancy negatively affects placental development and function in mice // J. Anim. Sci. 2012. 90. (13). 4846–4856.

56. Lo J.C., Grumbach M.M. Pregnancy outcomes in women with congenital virilizing adrenal gyperplasia // Endocr. Metab. Clin. 2001. 30(1). P. 207–29.

57. McKenna T.J., Cunningham S.K. The pathogenesis of adrenal and extra adrenal hyperandroge­nism // J. Steroid. Biochem. Mol. Biol. 1993. 45. (1–3). 117–121.

58. Moran C., Azziz R., Weintrob N. et al. Reproductive outcome of women with 21-hydroxylase-deficient nonclassic adrenlal hyperplasia // J. Clin. Endocr. Metab. 2006. 91. (9). 3451–3456.

59. Rabe T., Grunwald B., Runnebaum K. Hyperandrogenism in women // Gynec. Endocr. 2001. 7. 517–579.

60. Recabarren S.E., Sir-Petermann T., Maliqueo M. et al. Prenatal exposure to androgens as a factor of fetal programming // Rev. Med. Chil. 2006. 134. (1). 101–108.

61. Sun M., Maliqueo M., Benrick A. et al. Maternal androgen excess reduce placental and fetal weights, increase placental steroidogenesis and leads to long-terms health effects in their female offspring // Am. J. Physiol. Endocrinol. Metab. 2012. 303. E1373–E1385.